Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Systane® Ultra
- Registration Number
- NCT00946777
- Lead Sponsor
- Alcon Research
- Brief Summary
The primary objective is to determine if there is a correlation between reductions in corneal staining and improvements in corneal barrier function.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
- Patients must have moderate corneal staining and exhibit a need to use artificial tears.
Read More
Exclusion Criteria
- Patients can not participate in any other ophthalmic drug or device clinical trial within 30 days of the baseline visit.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Systane® Ultra Systane® Ultra -
- Primary Outcome Measures
Name Time Method Percent change from baseline of corneal fluorescein 30 days
- Secondary Outcome Measures
Name Time Method Adverse event occurence 30 Days